Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Dec;4(4):221-230.
doi: 10.1007/s40139-016-0114-6. Epub 2016 Sep 7.

Stromal Progenitor Cells in Mitigation of Non-Hematopoietic Radiation Injuries

Affiliations

Stromal Progenitor Cells in Mitigation of Non-Hematopoietic Radiation Injuries

Shilpa Kulkarni et al. Curr Pathobiol Rep. 2016 Dec.

Abstract

Purpose of review: Therapeutic exposure to high doses of radiation can severely impair organ function due to ablation of stem cells. Normal tissue injury is a dose-limiting toxicity for radiation therapy (RT). Although advances in the delivery of high precision conformal RT has increased normal tissue sparing, mitigating and therapeutic strategies that could alleviate early and chronic radiation effects are urgently needed in order to deliver curative doses of RT, especially in abdominal, pelvic and thoracic malignancies. Radiation-induced gastrointestinal injury is also a major cause of lethality from accidental or intentional exposure to whole body irradiation in the case of nuclear accidents or terrorism. This review examines the therapeutic options for mitigation of non-hematopoietic radiation injuries.

Recent findings: We have developed stem cell based therapies for the mitigation of acute radiation syndrome (ARS) and radiation-induced gastrointestinal syndrome (RIGS). This is a promising option because of the robustness of standardized isolation and transplantation of stromal cells protocols, and their ability to support and replace radiation-damaged stem cells and stem cell niche. Stromal progenitor cells (SPC) represent a unique multipotent and heterogeneous cell population with regenerative, immunosuppressive, anti-inflammatory, and wound healing properties. SPC are also known to secrete various key cytokines and growth factors such as platelet derived growth factors (PDGF), keratinocyte growth factor (KGF), R-spondins (Rspo), and may consequently exert their regenerative effects via paracrine function. Additionally, secretory vesicles such as exosomes or microparticles can potentially be a cell-free alternative replacing the cell transplant in some cases.

Summary: This review highlights the beneficial effects of SPC on tissue regeneration with their ability to (a) target the irradiated tissues, (b) recruit host stromal cells, (c) regenerate endothelium and epithelium, (d) and secrete regenerative and immunomodulatory paracrine signals to control inflammation, ulceration, wound healing and fibrosis.

Keywords: Epithelial Regeneration; Exosomes; Growth factors; Inflammation; Intestinal Stem Cells; Radiation Induced Gastrointestinal Diseases; Stromal Progenitor Cells; Vascularization.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Shilpa Kulkarni, Timothy Wang and Chandan Guha declare that they have no conflict of interest.

Figures

Figure 1
Figure 1
Beneficial effects of stromal progenitor cells in various stages of acute and chronic radiation injuries

Similar articles

Cited by

References

    1. Baskar R, Lee KA, Yeo R, Yeoh KW. Cancer and radiation therapy: current advances and future directions. International journal of medical sciences. 2012;9(3):193–199. PubMed PMID: 22408567. Pubmed Central PMCID: 3298009. - PMC - PubMed
    1. Barnett GC, West CM, Dunning AM, Elliott RM, Coles CE, Pharoah PD, et al. Normal tissue reactions to radiotherapy: towards tailoring treatment dose by genotype. Nature reviews Cancer. 2009 Feb;9(2):134–142. PubMed PMID: 19148183. Pubmed Central PMCID: 2670578. - PMC - PubMed
    1. Prasanna PG, Stone HB, Wong RS, Capala J, Bernhard EJ, Vikram B, et al. Normal tissue protection for improving radiotherapy: Where are the Gaps? Translational cancer research. 2012 Jun;1(1):35–48. PubMed PMID: 22866245. Pubmed Central PMCID: 3411185. - PMC - PubMed
    1. Saha S, Bhanja P, Kabarriti R, Liu L, Alfieri AA, Guha C. Bone marrow stromal cell transplantation mitigates radiation-induced gastrointestinal syndrome in mice. PloS one. 2011;6(9):e24072. PubMed PMID: 21935373. Pubmed Central PMCID: 3174150. - PMC - PubMed
    1. Ch'ang HJ, Lin LM, Chang PY, Luo CW, Chang YH, Chou CK, et al. Bone marrow transplantation enhances trafficking of host-derived myelomonocytic cells that rescue intestinal mucosa after whole body radiation. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology. 2012 Sep;104(3):401–407. PubMed PMID: 22260849. - PubMed

LinkOut - more resources